This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.
International immunopharmacology, 169, 116008
Citation
Zahedipour, Fatemeh; Vahdat-Lasemi, Fatemeh; Farhoudi, Leila; Hosseinikhah, Seyedeh Maryam; Amiri, Atefeh; Barati, Mehdi; Sankian, Mojtaba; Zamani, Parvin; Gheybi, Fatemeh; Jamialahmadi, Khadijeh; Jaafari, Mahmoud Reza. (2026). Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.. International immunopharmacology, 169, 116008. https://doi.org/10.1016/j.intimp.2025.116008